BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC ...Middle East

PR Newswire - News
Presented at 2023 SITC Meeting - A pre-planned biomarker analysis of patients treated with bemcentinib in combination with KEYTRUDA® (pembrolizumab) yields new understandings- BERGEN, Norway, Nov. 6, 2023 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical...

Hence then, the article about bergenbio announces data from biomarker analyses in 2l nsclc was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC )

Apple Storegoogle play

Last updated :

Also on site :